An Innovative RP-HPLC Strategy for Dual-Drug Analysis: Simultaneous Estimation of Selegiline and Biochanin A in Bulk and SNEDDS | Synapse
March 16, 2026
An Innovative RP-HPLC Strategy for Dual-Drug Analysis: Simultaneous Estimation of Selegiline and Biochanin A in Bulk and SNEDDS
Key Points
The research aims to develop a reliable method for estimating selegiline and biochanin A simultaneously.
Developed and validated a RP-HPLC method.
Used bulk drug and SNEDDS for analysis.
Assessed sensitivity and robustness of the method.
Successfully estimated both drugs concurrently.
Demonstrated high sensitivity and accuracy.
Validated method for practical applications in drug formulation.
Abstract
A simple, sensitive, and robust RP-HPLC method was successfully developed and validated for the concurrent estimation of SEL and BCA in bulk drug and SNEDDS.